SEC
DOJ Closes Investigation of CareDx Business Practices With No Wrongdoing Found
The DOJ decision follows the closure of an SEC investigation into the company's kidney and phlebotomy services, which also found no wrongdoing.
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
Illumina shareholders will receive one share of Grail for every six shares of Illumina stock, with cash issued in lieu of fractional shares.
Decision Diagnostics CEO Sentenced to Seven Years in Prison for Fraud Scheme
CEO Keith Berman was charged with defrauding investors of roughly $28 million by claiming to have developed a 15-second finger prick blood test for COVID-19.
Decision Diagnostics CEO Pleads Guilty to Fraud Over COVID-19 Test Claims
Prosecutors said Keith Berman falsely claimed since early in the pandemic that his firm was soon launching a 15-second blood test for COVID-19.
SEC Concludes CareDx Investigation, Recommends No Enforcement Action
The SEC informed CareDx in a letter that it had concluded an investigation into the company's accounting and public reporting practices.
Aug 10, 2023
SEC Investigating Illumina Over Grail Acquisition
Sep 2, 2021
Cue Health Files for IPO for up to $100M
Mar 31, 2021
Talis Biomedical 2020 Revenues Rise Sharply
Nov 13, 2020
Abbott Enters $5B Credit Agreement
Sep 11, 2020
Hologic Raises Q4 Revenue Guidance
Sep 9, 2020
Early Cancer Detection Firm Grail Files for IPO
Jun 16, 2020
Progenity Eyes $122.6M in Amended IPO
Jun 15, 2020
Genetron Health Targeting $175.5M in Amended US IPO
Jun 7, 2020
ArcherDx Targeting $100M in IPO
Feb 12, 2020
OpGen Preliminary 2019 Revenues up 19 Percent
Dec 17, 2019